Retrospective analysis of glioblastoma multiforme (GBM) patients treated initially with BCNU compared to temozolomide (TMZ) with concomitant radiation therapy

被引：0
|
作者：
Vinjamuri, M. [1 ]
Adumala, R. [1 ]
Altaha, R. [1 ]
Hobbs, J. [1 ]
Crowell, E. [1 ]
机构：
[1] West Virginia Univ, Morgantown, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2071
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Postmortem evaluation of end-organ toxicity in patients with glioblastoma (GBM) treated with temozolomide (TMZ) and bevacizumab (BEV).
    Zhu, J.
    Tian, X. J.
    Linendoll, N.
    Pfannl, R.
    Pilichowska, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Radiotherapy with concomitant and adjuvant temozolomide in glioblastoma multiforme patients: Compliance analysis.
    Cartei, F.
    Carau, B.
    Ursino, S.
    Api, P.
    Fiorica, F.
    Cerruti, S.
    Cavallo, M.
    Padovani, R.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S296 - S296
  • [43] Therapeutic results in patients with anaplastic astrocytoma (AA) or glioblastoma multiforme (GBM) receiving postoperative radiotherapy and concomitant temozolomide
    Zorlu, F.
    Sari, S.
    Ozyigit, G.
    Selek, U.
    Ulger, S.
    Gurkaynek, M.
    Kars, A.
    Tuerker, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 145 - 145
  • [44] MGMT expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ).
    Barrie, M.
    Eudes, N.
    Metellus, P.
    Fuentes, S.
    Honore, S.
    Boucard, C.
    Dufour, H.
    Figarella-Branger, D.
    Chinot, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 76S - 76S
  • [45] A PHASE II STUDY OF MULTIMODAL THERAPY EMPLOYING SURGERY, CARMUSTINE (BCNU) WAFER, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Rezazadeh, Arash
    LaRocca, Renato V.
    Vitaz, Todd W.
    Villanueva, Wayne G.
    Hodes, Jonathan
    Haysley, Leslie
    NEURO-ONCOLOGY, 2011, 13 : 90 - 90
  • [46] Phase II trial of radiation therapy/temozolomide followed by temozolomide/sorafenib in the first-line treatment of glioblastoma multiforme (GBM)
    Lamar, R. E.
    Spigel, D. R.
    Burris, H. A.
    Markus, T. M.
    Kuzur, M.
    Ervin, T.
    Fichtel, L.
    Greco, F. A.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Results of a Phase 2 Clinical Trial of Neo-Adjuvant Temozolomide (TMZ), Followed by Concurrent TMZ and Hypofractionated Accelerated External Beam Radiation Therapy (Ac-EBRT) With Limited Margins, and Adjuvant TMZ for Patients With Glioblastoma Multiforme (GBM)
    Shenouda, G.
    Souhami, L.
    Panet-Raymond, V.
    Abdulkarim, B.
    Cury, F.
    Owen, S.
    Kavan, P.
    Petrecca, K.
    Guiot, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S160 - S160
  • [48] A Phase 2 Trial of Neoadjuvant Temozolomide (TMZ) Followed By Accelerated Hypofractionated Radiation Therapy (AHRT) and TMZ Followed By Adjuvant TMZ in Patients with Newly Diagnosed Glioblastoma (GBM): Long Term Survival and Toxicity Analysis
    Shenouda, G.
    Souhami, L.
    Petrecca, K.
    Owen, S.
    Panet-Raymond, V.
    Carvalho, T.
    Guiot, M. C.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S48 - S49
  • [49] Impact of karnofsky performance status (KPS) on outcome of elderly patients with glioblastoma (GBM) and activity of temozolomide (TMZ) as first-line therapy:: Retrospective analysis of a cohort
    Chinot, O. L.
    Barrie, M.
    Calissi, B.
    Fuentes, S.
    Metellus, P.
    Honoré, S.
    Boucard, C.
    Loundou, D. A.
    Figarella-Branger, D.
    NEURO-ONCOLOGY, 2006, 8 (04) : 302 - 302
  • [50] A Phase 2 Trial of Hypofractionated-Intensity Modulated Radiation Therapy (Hypo-IMRT) Combined With Temozolomide (TMZ) and Bevacizumab (BEV) for Patients With Newly Diagnosed Glioblastoma Multiforme (GBM)
    Carlson, J. A.
    Ney, D.
    Reddy, K.
    Gaspar, L. E.
    Kavanagh, B. D.
    Damek, D.
    Lillehei, K. O.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S284 - S285
12345